Aug 14, 2024, 07:32 AM by

Aug 14, 2024, 07:32 AM by

Sapio Sciences, the science-aware™ lab informatics platform, today announced a new strategic partnership with CREO, the preferred consultancy to the world’s most promising companies that seek to improve human health, to deliver comprehensive, end-to-end laboratory information management solutions.

Aug 14, 2024, 07:32 AM by

Champalimaud Foundation, a cutting-edge biomedical clinical research organization, adopts Lonza's MODA-ES® Platform at the Champalimaud Clinical Centre in Lisbon, Portugal.

Aug 14, 2024, 07:32 AM by

eClinical Solutions announced newly released product enhancements and AI-enabled functionality within the elluminate Clinical Data Cloud ®. Recent platform updates offer clinical teams increased oversight and efficiency amid trial complexity and advance the AI technology footprint of life sciences organizations.

Aug 14, 2024, 01:00 AM by User Not Found

Bio-IT World | For more than a dozen years, Tom Plasterer has held roles at AstraZeneca both in research IT and in more science-facing positions including translational medicine. Along the way, he was beating the drum for FAIR data—data that are Findable, Accessible, Interoperable and Reusable— and knowledge graphs, playing an active role in both the FAIR community and the Pistoia Alliance.

Aug 13, 2024, 08:17 AM by

Aug 13, 2024, 05:00 AM by User Not Found

Bio-IT World | The cost of bringing a drug to market has, by some estimates, ballooned to $3 billion and the central problem could be the “misapplication of technology.” Since completion of the Human Genome Project, the focus had shifted heavily toward orphan drugs with a single genetic target, suitable only to highly targeted genetic technology platforms.

Aug 12, 2024, 07:53 AM by

Aug 12, 2024, 07:53 AM by

Vaxess Technologies, Inc., a life sciences company developing a novel transdermal patch technology to transform home delivery of therapies and vaccines, today announced that Peter Kolchinsky, PhD, co-founder and managing partner at RA Capital Management, has joined Vaxess’s board of directors.

Aug 12, 2024, 07:53 AM by

Groundbreaking collaboration to advance understanding of autoimmune diseases and environmental determinants of diabetes

Aug 9, 2024, 06:55 AM by

Aug 9, 2024, 06:54 AM by

ECI (Enhanced Compliance Inc.), a leading provider of regulatory, quality and engineering services and solutions for the life sciences industries, today announced the appointment of Brijesh Patel as the company’s new Chief Executive Officer (CEO), replacing Hoyt Randall Smith, who has announced his retirement.

Aug 9, 2024, 06:54 AM by

Phreesia, a leader in patient intake, outreach and activation, is pleased to announce it has named Bob Glazer as a Strategic Advisor, leveraging his deep expertise and decades of experience in healthcare leadership to help ensure its offerings continue to meet the evolving needs of its clients.

Aug 8, 2024, 12:52 PM by User Not Found

Bio-IT World | Recursion and Exscientia have entered into a definitive agreement to combine Recursion’s scaled biology exploration and translational capabilities with Exscientia’s precision chemistry design and small molecule automated synthesis capabilities.

Aug 8, 2024, 04:49 AM by

Endor Labs, the leader in software supply chain security, today unveiled two groundbreaking capabilities that fix an expensive and time-consuming problem in the Software Composition Analysis (SCA) market.

Aug 8, 2024, 01:00 AM by User Not Found

Bio-IT World | Singapore’s National Precision Medicine (NPM) program has launched a long-read sequencing project to gain deeper insights into Asian genetic diversity. The program, Precision Health Research, Singapore (PRECISE) has appointed both Oxford Nanopore Technologies (ONT) and PacBio (PacBio) to deliver sequencing.

Aug 7, 2024, 06:36 AM by

Aug 7, 2024, 05:00 AM by User Not Found

Bio-IT World | At last year’s Bio-IT World Conference & Expo, AbbVie won an Innovative Practices Award for their AbbVie R&D Convergence Hub (ARCH). Their data platform is designed to provide access to knowledge in a faster and more automated way, as well as an easier way to extract insights and connect disparate datasets. Today, three years after the launch of ARCH, AbbVie has made great strides in data convergence with the platform.

Aug 6, 2024, 07:40 AM by

Aug 6, 2024, 07:40 AM by

Rho, a full-service contract research organization (CRO), has appointed leading neurologist Dr. Andrew Feigin as its new chief medical officer (CMO). In this pivotal global role, Dr. Feigin will provide strategic medical and operational expertise across multiple therapeutic areas, ensuring the integrity and safety of Rho’s clinical trials. Dr. Feigin's career is marked by groundbreaking contributions to neurology and clinical research. He served as the site principal investigator on more than 30 clinical trials, notably spearheading the first phase 1 clinical trial using gene therapy for Parkinson's disease. His prolific contributions to the field include over 150 peer-reviewed articles and numerous advisory board positions.